BridgeMD
New treatment option for Cardiac Arrest
Official title Hypertonic Lactate After Cardiac Arrest
ClinicalTrials.gov ID: NCT05004610
What this study is testing
What is Sodium Lactate Solution?
Sodium Lactate Solution is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for cardiac arrest.
Also referred to as Hyperonic sodium lactate.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study is intended to test the hypothesis that sodium lactate infusion after resuscitation from a cardiac arrest will decrease the magnitude of brain damage, as measured by the serum biomarker concentration of NSE.
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age \> 18 years old
- Sustained (\> 20 minutes) return of spontaneous circulation (ROSC)
- Comatose (GCS \< 9)
- Time to ROSC \> 15'
You likely can't join if
- Protected categories (Pregnant women)
- Anticipated withdrawal of support within 24 hours
- Traumatic cause of cardiac arrest
- Body weight at admission \> 120Kg
The study team makes the final eligibility decision.
Where it's taking place
- Brussels, Belgium, Belgium
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brussels, Belgium, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.